Product Image

Monolaurin 500 mg

Solaray
4.9
★ ★ ★ ★ ★
(30890 ratings)
Monolaurin 500 mg
Product Image
Score84
Transparent coconut-derived glycerol monolaurate and a practical 500 mg capsule make this a well-rounded focused option. It remains better for targeted use than broad daily nutrition.
How scoring works
Quantity:60 VegCap(s) • (60 servings)
Goals:
Immunity

Score 84

Transparent coconut-derived glycerol monolaurate and a practical 500 mg capsule make this a well-rounded focused option. It remains better for targeted use than broad daily nutrition.
How scoring works
$15.82($0.26 per serving)
Vitacost
$ 15.99
Pure Formulas
$ 15.99
iHerb
$ 15.99
Amazon
$ 15.82
Report prices

Analysis

The label clearly identifies the active as coconut-derived glycerol monolaurate and supplies 500 mg in one capsule. That form and source disclosure removes a major uncertainty found in many competing monolaurin products.

A single-active design is easy to understand and allows targeted use without unrelated ingredients. The amount is meaningful, though products with higher serving amounts may suit people prioritizing maximum monolaurin per serving.

Good value and a one-capsule serving strengthen its everyday practicality. Its fit is still specific: monolaurin does not cover the vitamins, minerals, antioxidants, or barrier-support pathways expected from broad immune nutrition.

Who is it for
  • Adults who want clearly identified glycerol monolaurate
  • People seeking a one-capsule monolaurin serving
  • Users who value source transparency
Best for
  • Transparent monolaurin form and source
  • A practical 500 mg serving
  • Focused single-ingredient use

Pros

  • Identifies glycerol monolaurate form
  • States coconut as the source
  • Good value with a one-capsule serving

Cons

  • Lower active amount than some high-strength options
  • Single active offers limited pathway coverage
  • Not a substitute for foundational immune nutrients

Nutrient quality

92 Highest impact

Clear glycerol-monolaurate identity and coconut sourcing provide strong form quality. A meaningful single-capsule amount keeps the formula focused and balanced.

.

Ingredient transparency

75 High impact

Active amounts are listed and no proprietary blend hides the supplied doses. Missing complete directions, excipients, and some source or standardization details keep disclosure incomplete.

.

Customer satisfaction

74 High impact

An exceptional supplied average is backed by an exceptionally large review base. Specific review comments were not provided, so repeated complaints and purpose-specific experiences cannot be assessed.

.

Value for money

94 Highest impact

Clear form and source disclosure combine with a favorable serving cost for strong value. The concise formula avoids the uncertainty of poorly defined companion ingredients.

.
Report analysis

Goals

Immunity
Impact
High effect
F Goal FitA- Strength of SupportD CoverageA Formula Quality
Monolaurin · 500 mg

Coconut-derived glycerol monolaurate is clearly identified and supplied at a meaningful targeted amount. Even so, monolaurin has a narrow fit with general health and much less established human evidence than foundational nutrients.

The formula is transparent and easy to use, with no hidden blend. Its suitability depends on a specific reason for monolaurin rather than broad daily nutritional support.

Study evidence
Monolaurin Not classified 1 study

Ingredients

IngredientAmount per serving
Monolaurin (Coconut, Glycerol Monolaurate)
500 mg
Adults 18–50
Report overview
A+ Active Ingredient Quality & BioavailabilityA Dose, Safety & Label TransparencyB Value

The clearly identified coconut-derived glycerol monolaurate provides a strong standard amount in one capsule. The dose is fully disclosed and easy to take. Cost efficiency is good for the active amount delivered.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels due to glycerol monolaurate in tampons
    Kristi L Strandberg, Marnie L Peterson, Matthew M Schaefers, Laura C Case, Melinda C Pack, David J Chase, Patrick M Schlievert · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2009
    Randomized trial225 participantsImmunity forMonolaurin